share_log

Analyst Ratings For AtriCure

Benzinga ·  Jul 9, 2024 03:01

AtriCure (NASDAQ:ATRC) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings42000
Last 30D10000
1M Ago00000
2M Ago00000
3M Ago32000

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $40.17, with a high estimate of $49.00 and a low estimate of $32.00. A decline of 13.05% from the prior average price target is evident in the current average.

1720465269_0.png

Investigating Analyst Ratings: An Elaborate Study

The standing of AtriCure among financial experts becomes clear with...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment